Table 3 Gastrointestinal symptoms, feeding issues and medications at pre-baseline, during the short-term evaluation (28Â days) and extended follow-up (12Â months)
From: Phenylalanine free infant formula in the dietary management of phenylketonuria
|  | Pre-baseline (n = 10) | Short-term a (28 days, n = 10) | Long-term (12 months, n = 7) |
|---|---|---|---|
Gastrointestinal symptoms (n, %) | |||
 Constipation | 7 (70%) | 6 (60%) | 0 (0%) |
 Colic | 5 (50%) | 3 (30%) | 1 (14%) |
 Vomiting | 3 (30%) | 3 (30%) | 2 (29%) |
Stool consistency (n, %) | |||
 Soft | 6 (60%) | 8 (80%) | N/A |
 Loose | 4 (40%) | 1 (10%) | N/A |
 Hard | 0 (0%) | 1 (10%) | N/A |
Poor feeding (n, %) | 5 (50%) | 3 (30%) | 1 (14%) |
Medications (n, %) | Â | Â | Â |
 Laxatives | 2 (20%) | 2 (20%) | 0 (0%) |
 Colic treatment | 2 (20%) | 1 (10%) | 0 (0%) |
 Antacids/antiemetics | 1 (10%) | 1 (10%) | 1 (14%) |